Can compliance in pharmaceutical logistics by air be reached through industry collaboration?
Pharmaceuticals makeup 1.9% of all air cargo and generate revenues of $1.4 billion per year - 2.6% of total air cargo. In the next three years (2018-2020), growth in pharmaceuticals being transported by air is...
A stay at the Stem Cell Hotel
By Davide Danovi - Director, HipSci Cell Phenotyping Programme, Centre for Stem Cells and Regenerative Medicine, King’s College London
All cells in our body came from one original cell - a fertilised egg. A blood...
The surprising Science of fat: You can get fatter and become healthier
A new study in obese mice suggests that increasing the growth of fat located under the skin (subcutaneous) actually led to an improvement in glucose tolerance and insulin sensitivity, both precursors to diabetes. The...
Simplicity is all
In this issue of BioScience Today, Ellen Rossiter speaks to Professor Kawal Rhode about his work in the realm of biomedical engineering, his inspiration, motivation and why simplicity is all.
“Way back in school, we...
Matching clinical trials with unmet clinical need
A new tool that helps target clinical trials to areas of unmet clinical need has sparked interest in both the National Health Service (NHS) and the commercial clinical research world. Stephen Lock, Head of...
Biosample provenance: what researchers need to know
Why is the current system for sourcing samples broken? And what does this mean for researchers who use biosamples? Robert Hewitt, MB BS, PhD, of Biosample Hub, investigates.
The journey for every biospecimen used for...
Safe’n’Sound®, a customizable platform of add-on passive safety devices for prefilled syringes
In the parenteral industry, Needlestick injuries remain a global concern with over 3 million exposures to blood occurring every year according to the World Health Organization (WHO).
Sharps injuries result in not only health issues...
UK ‘Octopus’ trial tackling multiple sclerosis is a world first
A ground breaking mega-trial for progressive multiple sclerosis will be launched in the UK later this year.
Octopus, so called because of its multiple arms, is a revolutionary clinical trial that will transform the way...
Artificial Neural Networks working with Image Guided Therapies to improve heart disease treatment
By Rashed Karim
Research Fellow at King’s College London School of Biomedical Engineering and Imaging Sciences
It’s exciting to envisage that future treatments for cardiovascular disease will be supported by intelligent systems and devices. At the...
Human factors and prefilled syringes
Human factors is now firmly established at the heart of medical device development, and that includes prefilled syringes. Regulators, and in particular the US Food and Drug Administration (FDA) have recently published guidance on...
New life sciences cluster in Paddington will champion health partnerships
Imperial College Healthcare NHS Trust has set out its vision for a new life sciences cluster in Paddington, founded on its growing partnerships with research, industry and community organisations around St Mary’s Hospital.
The Trust...
PROFESSOR HONOURED FOR HER WORK ON PANDEMIC CONTROL
A Women in Science event held earlier this year demonstrated that women are certainly coming into their own in the fields of science, technology, engineering and maths.
In this, the final feature in a three-part...
The rise of biotechnology: How biotechnology is contributing to regional development
SMITH, D.J., ROSSITER, W. and MCDONALD-JUNOR, D., Nottingham Business School, Nottingham Trent University
How a city creates new development paths when faced with declining industries, is one of the most pressing questions of our time. We’ll...
Life Science success
Whilst the recent past has been one of huge uncertainty with regards to the political and economic landscape across the globe, the past year saw major success in Life Sciences & Healthcare across the...
Key success factors for biosimilars
Global regulatory pathways for biosimilar development are continually evolving. Many countries throughout the world have established legal and regulatory pathways which allow development of biosimilar products.
The European Union (EU) was the first region in...
Biosimilars – What are the critical regulatory milestones during development and registration?
The ever increasing complexity of regulations and drug approval pathways has converted regulatory intelligence into one of the key assets during any kind of drug development.
This situation is even more pronounced in the case...